packagePembrolizumab

pembrolizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pembrolizumab is a monoclonal antibody that blocks PD-1 and is used to treat several cancers, including melanoma, lung, bladder, kidney, head and neck, and endometrial cancers. It is approved and widely used, including an authorised product in the European Union.

Summary written by glm-5.3-flash from Wikidata Q13896859 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:pembrolizumab
ATC codes:L01FF02
DrugBank:DB09037
Wikidata:Q13896859
molar mass:149000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown